In this study, we investigated the utility of a replication-deficient adenoviral vector containing the cDNA encoding a secreted, EpCAM-targeted form of human liver CE2, Ad.C28-sCE2, to sensitise colon cancer tumours to CPT-11. Here, EPCAM is linked to neoplasm.